Obesity hypoventilation syndrome
What it is
Obesity hypoventilation syndrome, shortened to OHS, is a disorder in which central obesity leads to chronic hypoventilation, due at least in part to restricted diaphragm excursion.
How it presents
Shortness of breath that has slowly worsened over months, without cough or chest pain, in a person whose history is significant only for obesity. A described example: walking only 10 feet before becoming short of breath, a BMI of 42.4, an oxygen saturation of 92% on room air, a heart with a regular rate and rhythm and no murmurs, lungs clear to auscultation, bilateral 1+ edema of the lower extremities, and a normal chest radiograph.
How it is diagnosed
Current criteria are three: first, hypoventilation leading to carbon dioxide retention, meaning a PaCO2 above 45 mm Hg; second, a BMI above 30 kg/m2; third, that other causes of chronic alveolar hypoventilation have been ruled out. These patients retain bicarbonate to compensate for the respiratory acidosis, and it has been suggested that an increased serum bicarbonate above 29 mEq/L, in the absence of another cause for metabolic alkalosis, should be included in the definition. A serum bicarbonate of 35 mEq/L against a normal range of 22 to 29 is the kind of value seen. Spirometry shows a restrictive pattern, and this is what separates OHS from the conditions it is confused with:
- Asthma and COPD are obstructive lung diseases, so they are excluded when there are no signs of airway obstruction on spirometry
- Obstructive sleep apnea is often present alongside OHS, but sleep apnea alone does not lead to daytime hypoventilation and carbon dioxide retention
- Pulmonary fibrosis is also restrictive and is not excluded by spirometry, though a normal chest radiograph makes it less likely; comprehensive pulmonary function testing, including the diffusion capacity of the lung for carbon monoxide (DLCO), would help rule it out, because pulmonary fibrosis leads to a decreased DLCO while OHS does not